Intra-Cellular Therapies ...

AI Score

0

Unlock

128.57
-0.03 (-0.02%)
At close: Feb 20, 2025, 3:59 PM
128.96
0.30%
After-hours: Feb 20, 2025, 05:38 PM EST

Intra-Cellular Therapies Inc. Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for ITCI stock have an median target of 100, with a low estimate of 74 and a high estimate of 132. The median target predicts a decrease of -22.22% from the current stock price of 128.57.

Analyst Consensus: Hold
Target Low Average Median High
Price $74 $103.62 $100 $132
Change -42.44% -19.41% -22.22% 2.67%

AI Analyst Report

RBC Capital has downgraded Intra-Cellular Therapie... Unlock content with Pro Subscription

Updated Jan 22, 2025

Rating Jul 24Aug 24Sep 24Oct 24Nov 24Jan 25
Strong Buy 100000
Buy 053410
Hold 020004
Sell 000000
Strong Sell 000000
Total 1 7 3 4 1 4

Financial Forecast this Year

Revenue This Year
675.07M
from 464.37M
Increased by 45.4%
Revenue Next Year
927.75M
from 675.07M
Increased by 37.4%
EPS This Year
-0.63
from -1.46
Increased by 56.8%
EPS Next Year
0.65
from -0.63
Increased by -3.2%